MEDTRN — Meditrina Cyprus Balance Sheet
0.000.00%
- €4.50m
- €2.77m
- €7.34m
Annual balance sheet for Meditrina Cyprus, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.281 | 0.44 | 0.32 | 0.112 | 3.42 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.42 | 4.11 | 3.34 | 3.35 | 3.96 |
| Total Inventory | |||||
| Total Current Assets | 6.46 | 7.74 | 4.32 | 3.99 | 7.74 |
| Net Property, Plant And Equipment | 0.028 | 0.032 | 0.003 | 0.003 | 0.003 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 15.6 | 17.2 | 14.4 | 14.4 | 17.2 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.29 | 8.57 | 6.03 | 5.94 | 5.18 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9.46 | 11.5 | 7.98 | 7.57 | 6.71 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 6.19 | 5.77 | 6.41 | 6.79 | 10.5 |
| Total Liabilities & Shareholders' Equity | 15.6 | 17.2 | 14.4 | 14.4 | 17.2 |
| Total Common Shares Outstanding |